68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)

NARecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Primary AldosteronismAutonomous Cortisol Secretion
Interventions
DIAGNOSTIC_TEST

68Ga-Pentixafor PET/CT

Patients in the 68Ga-Pentixafor PET/CT group will first undergo 68Ga-Pentixafor PET/CT, followed by adrenal venous sampling (AVS). The subsequent treatment will be guided based on the diagnostic results.

DIAGNOSTIC_TEST

AVS

Patients in the adrenal venous sampling (AVS) group will first undergo adrenal venous sampling (AVS), followed by 68Ga-Pentixafor PET/CT. The subsequent treatment will be guided based on the diagnostic results.

Trial Locations (1)

Unknown

RECRUITING

The First Affilated Hospital of Chongqing Medical University, Chongqing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Affiliated Hospital Of Southwest Medical University

OTHER

collaborator

Changzhi Medical College

OTHER

collaborator

First Affiliated Hospital of Kunming Medical University

OTHER

lead

Qifu Li

OTHER